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The preceding paper contains the results of various reinoculation experiments in which the viruses of rabbit pox, virus I I I disease, infectious m y x o m a of rabbits, culture (dermo) vaccinia, and neurovaccinia were compared (1) . The findings with respect to the reaction of recovered rabbits to exposure to clinical cases of pox, together with the observations on a calf inoculated with pox, two specimens of vaccine virus, and neurovaccine were also reported. The present paper is concerned with the results of the serum neutralization tests in which various combinations of the viruses and the immune sera of pox, vaccinia, neurovaccinia, and virus I I I were studied.
Materials and Methods
The various virus emulsions were prepared from tissues obtained from cases of acute orchitis produced by intratesticular injection of tissue-virus. The testicles were ground with alundum and Locke's solution to make a suspension of 10 to 20 per cent concentration by weight. Gross particles were removed by low speed centrifugation. The emulsions were kept in the ice box while their bacterial sterility was tested.
The immune sera were obtained from rabbits inoculated 17 to 134 days previously or in the case of spontaneous pox, a fortnight or more after all signs of the disease had healed. Each specimen was kept in sealed tubes in the ice box. The sterility of each serum was tested before tubing and before use.
The tests were carried out in the usual manner. Desired dilutions of virus or serum were made with Locke's solution. Equal parts of tissue-virus emulsion and of serum were thoroughly mixed in small sterile Petri dishes and allowed to stand at room temperature 1½ to 2½ hours; 0.2 cc. of the mixture was then injected 379 in normal adult rabbits intradermally on the shaved skin of the side of the body.
In certain experiments, it was necessary to inject mixtures of more than one virus in the same animal. The combinations of a different immune sera with a particular virus were injected in the same rabbits. Appropriate control mixtures of virus and normal serum and of virus and the homologous immune serum were made. Each set of tests was done on 2 animals. The animals were examined daily. The results were usually limited to the findings of a week on account of the pronounced disease with its marked constitutional symptoms produced by pox virus (2, 3) .
RESULTS AND DISCUSSION
The results of the serum-virus neutralization experiments are presented in the following order: First, the observations on the neutralizing action of pox immune serum against pox virus; second, the findings with respect to virus III immune serum and pox virus; and third, the action of culture (dermo) vaccine and neurovaccine immune sera against pox virus and the action of pox immune serum against culture vaccine and neurovaccine viruses. It seems best to discuss the results of each group of experiments as they are presented. The major interest in the findings centers around the experiments in which pox and vaccine immune sera were compared, for it was found that pox immune serum had a marked neutralizing action against pox virus, vaccine virus, and neurovaccine. Vaccine immune serum had a partial neutralizing power against pox virus and neurovaccine immune serum was more potent in this respect than culture vaccine immune serum. Virus III immune serum, on the other hand, had no neutralizing action against pox virus. Summarized typical protocols of several sets or groups of experiments have been selected for discussion of the results obtained (Tables I to IV) .
Pox Immune Serum-Pox Virus Tests.--It was found that pox immune serum possessed marked neutralizing properties against pox virus.
In the first experiments in which pox immune, culture vaccine immune, and virus III immune sera were compared with respect to their neutralizing action against pox virus, the serum-virus mixtures comprised full strength serum plus various virus dilutions up to 1:100,000. Three pox immune sera were tested, two from experimental cases obtained 31 and 33 days after inoculation and one from a spontaneous case obtained approximately a month after clinical signs had healed. The virus employed was derived from the 8th, 10th, and lSth serial rabbit passage of the Xyl71 strain (2) . A total of 28 pox immune serum-pox virus mixtures were tested on 6 rabbits.
The results showed that with two partial exceptions undiluted pox immune serum completely neutralized diluted and full strength pox virus, whereas normal serum possessed no neutralizing properties whatever. The findings on 2 rabbits are summarized in Tables I  and II. The partial exceptions occurred in 2 animals injected with the same serumvirus mixtures and comprised modified positive reactions to the mixtures containing full strength virus and the dilutions of 1:10 and 1:100. The protocol of 1 animal is given in Table II .
The lesions which did not develop before the 4th day were irregular somewhat nodular areas of cutaneous thickening with moderate congestion. There was little or no hemorrhage and no edema or necrosis, and within 2 days regression had begun. The sluggish non-progressive character of these lesions contrasted sharply with the actively progressing lesions produced by pox virus mixed with normal serum which began within 24 to 48 hours after injection and in which hemorrhage, edema, and necrosis were conspicuous even in virus dilutions of 1 : 10,000 and 1 : 100,000. This modified reaction, however, was not seen in another experiment in which the same specimen of serum completely neutralized all dilutions of pox virus.
The results of the experiments in which dilutions of pox immune serum as well as dilutions of virus were used will be described later in connection with the observations on the neutralizing action of vaccine immune serum.
Virus III Immune Serum-Pox Virus Tests.--Virus III immune serum did not exhibit any neutralizing properties against pox virus in the one experiment in which this combination was tested.
The serum was obtained 25 days after inoculation and in full strength combinations it completely neutralized the homologous virus. Pox virus in dilutions of 1:1 to 1:1,000 with full strength serum was employed (Table I) . A characteristic cutaneous lesion was obtained with each mixture. They were entirely comparable to those resulting from the injection of normal serum-pox virus mixtures as regards time of development, appearance, and course of the lesions (Table I) .
Since these results were in complete agreement, first, with those obtained in the crossed inoculation experiments with virus nI and pox recovered rabbits in which the animals were found to be susceptible Both culture (dermo) vaccine and neurovaccine immune sera were used. The first experiments were carried out with sera of 2 rabbits inoculated with culture tissue-virus 17 and 24 days before blood was withdrawn. The serum-virus mixtures were similar to the pox immune serum-pox mixtures previously described, that is, virus dilutions up to 1:100,000 combined with full strength serum, and the injections numbering 28 were made on the same rabbits. The protocols of 2 animals are given in Tables I and II. The character of the action of vaccine immune serum on pox virus can best be appreciated by recalling first the complete neutralizing properties of pox immune serum against pox virus described above, and second the high potency of the virus itself (Tables I and II) .
With normal serum-pox virus mixtures, a positive reaction with virus dilutions of 1:1 to 1:10,000 developed on the 1st and 2nd days and in the dilutions of 1:100,000 on the 3rd day. The cutaneous lesions increased very rapidly and soon comprised large swollen areas in which edema, congestion, hemorrhage, and necrosis were conspicuous features. It should be noted that as late as the 7th day little or no regression had occurred.
The cutaneous reactions resulting from injections of culture immune serum-pox virus mixtures developed later and were much less pronounced than those of the normal serum-pox virus mixtures, a finding which indicates a definite neutralizing action (Tables I and II) . The effect was especially evident in the higher virus dilutions. For example, on the 4th day, as is shown in the protocol in Table II , the lesion of the 1 : 1,000 virus dilution with normal serum was pronounced (+ + + +) while with vaccine immune serum the reaction was positive for the first time (+). The vaccine immune serum-pox virus lesions were smaller, shallower, and less destructive, and there was much less edema and necrosis. But it was clearly evident that in comparison with the marked neutralizing effect of pox immune serum against pox virus, vaccine immune serum was very much less potent. On the other hand, pox immune serum was just as effective in neutralizing (Table II, In this connection the confirmatory results of another experiment are of interest. Neutralization tests were made with two" specimens of serum from a rabbit, the first of which, serum A, was obtained 27 days after inoculation with culture vaccine virus and the second, serum B, which was obtained 14 days after the vaccinated rabbit had been inoculated with pox virus. The tests made on 2 rabbits comprised mixtures of serum A and serum B with pox virus and similar combinations with vaccine virus. Equal parts of full strength serum with 3 dilutions of Virus, 1:1, 1:10, and 1:100 respectively were used. All the control tests comprising normal serum and virus dilutions of 1:10 and 1:100 were positive. In the case of the 12 mixtures containing vaccine Virus, 6 with serum A and 6 with serum B, no reactions were observed, that is, complete neutralization of virus had been accomplished. In the case of the 6 mixtures containing pox virus and serum A (vaccine immune serum), well marked lesions developed from the 1:1 and 1:10 virus dilutions but not from the 1:100 dilutions, a result which is in accord with those previously described, namely, that vaccine immune serum has partial neutralizing properties against pox virus. On the other hand, the injections of the 6 mixtures of pox virus and serum B (vaccine and pox immune serum) gave negative results in all instances.
Of particular interest was the peculiar appearance and course of the cutaneous lesions produced by the vaccine immune serum-pox virus mixtures as is shown by the photographs in Figs. 1 to 4 taken on the 3rd, 4th, 5th, and 9th days respectively. The first visible reaction was observed 2 to 3 days after injection and comprised large circular pinkish yellow areas with rather ill defined margins which corresponded to slight but definite superficial cutaneous swellings (Fig. 1) . Within 24 to 48 hours the swelling had increased markedly in depth, especially at the periphery, so that the lesions had a crater-like appearance. There was little if any increase in the diameter of the involved area. Particularly striking was the nodular character of the lesions which was most marked at the periphery (Figs. 2 and 3) . The overlying skin became congested and some hemorrhage developed together with small punctate necroses. These features were also more conspicuous around the circumference than in the depressed central portion. Edema was not conspicuous, whereas in the case of intradermal injections of pox virus it was usually very pronounced and extensive. During the next 2 or 3 days the lesion usually became larger and more uniform in depth, thus losing something of its crater-like appearance, but the areas of necrosis tended to preserve their peripheral distribution (Figs. 3 and 4) . By the end of a week regression had begun and healing proceeded more rapidly than with the usual pox lesions, probably because tissue destruction was less extensive.
In some instances the lesions induced by vaccine immune serum-pox virus mixtures containing full strength virus failed to develop beyond the initial stage of swelling and congestion ( Figs. 1 and 2 ) and underwent rapid regression and healing (Figs. 3 and 4) . It might be thought that this result was due to specific antibodies contained in the tissue emulsion of pox virus which conditions of dilution in the other mixtures rendered incapable of effect. A similar finding was observed on two occasions with pox immune serum as has been previously described, but none was observed in the case of mixtures of full strength pox virus with normal or with virus IIIjmmune sera.
The experiments with neurovaccinel!comprised a series of tests in which were compared the neutralizing properties of pox immune, culture vaccine immune, and neurovaccine immune sera against the three viruses.
Each virus was prepared from pooled testicular tissue from 3 rabbits with an acute orchitis. Pooled immune serum was used, each being composed of equal amounts of six specimens derived from different rabbits. The intervals between inoculation and bleeding varied from 17 to 72 days. Each test was carried out in duplicate by the intradermal injection of 0.2 cc. of each inoculum on 2 rabbits. Mixtures containing pox virus were injected on the right side of the body, those containing culture vaccine virus on the upper left, and those containing neurovaccine on the lower left side respectively.
The strength or titer of the three viruses was first determined by intradermal injections of dilutions ranging from 1: 100 to 1: 1,000,000.
1 The experiments with neurovaccine were restricted by the available space which could be satisfactorily quarantined. Three individuals were allowed access to the two rooms set aside for this work, and these persons did not go to other animal rooms or laboratories while the experiments were in progress. A strict routine of hand disinfection and change of laboratory coats was maintained. At the conclusion of the experiments, all remaining stock was killed and the rooms were thoroughly disinfected with lysol. As far as is known, no spread of neurovaccinla occurred.
The results which are summarized in the following tabulation showed that positive reactions were obtained by 1:1,000,000 dilutions of both pox and neurovaccine viruses and by a l: 100,000 dilution of culture vaccine virus. The highest dilutions which produced comparable cutaneous reactions of fair size, however, were: pox virus 1:100,000, neurovaccine virus 1: 10,000, and culture vaccine virus 1: 1,000. The neutralizing potency of each immune serum against its homologous virus was next tested by intradermal injection of serum-virus mixtures in which varying dilutions of serum were mixed with a constant dilution of virus: 8 dilutions of serum ranging from 1:10 to 1:5,000,000 were employed. The virus dilutions used were selected on the basis of the previous findings, that is, pox 1:100,000, neurovaccine 1: 10,000, and culture vaccine 1: 1,000.
Preliminary Test on the Potency of the Viruses
The results, the relevant portions of which are summarized in the following tabulation, showed that the highest dilution of pox immune serum which neutralized pox virus (1:100,000) was 1:100; that of neurovaccine immune serum which neutralized neurovaccine virus (1 : 10,000) was 1:10; and that of culture vaccine immune serum which neutralized culture vaccine virus (1: 1,000) was 1:10. Tables III and IV. In the first experiment pox virus in a dilution of I:100,000 was used (Table  III) . This dilution was neutralized in both test animals by pox immune serum diluted 1:100 and in one animal by a 1:1,000 dilution. It was also neutralized by a 1 : 10 dilution of neurovaccine immune serum and in one animal by a 1 : 100 dilution while with culture vaccine immune serum the neutralization level was 1:10 in both rabbits.
The dilution of neurovaccine virus employed, 1:10,000, was ten times as concentrated as the dilution of pox virus used. The upper level of neutralization with both neurovaccine immune serum and culture serum was the dilution Of 1:I0, but in the case of pox immune serum it was 1:100 in both animals and 1:1,000 in one of them.
With culture vaccine virus only the results on one rabbit are available. The These results indicate a degree of similarity or inter-relationship between the three immune sera. As was to be expected, the neutralizing properties of each serum for its homologous virus were demonstrated, thus confirming the previous findings obtained in the preliminary tests; but in addition it was found that each serum also possessed some measure of neutralizing action against the two heterologous viruses. Pox immune serum had a potent neutralization action against pox virus, but the 2 lower dilutions of both neurovaccine and culture vaccine immune sera also neutralized pox virus. Pox immune serum was more potent against neurovaccine virus than either neurovaccine or culture vaccine immune serum; and it was more effective against culture vaccine virus than culture vaccine immune serum. Culture vaccine and neurovaccine immune sera gave almost identical results with respect to the dilutions at which they neutralized pox and neurovaccine viruses; in both cases the sera were not as potent as pox immune serum. On the other hand, the tests with culture vaccine virus showed that it was neutralized by the same dilutions of neurovaccine immune serum and pox immune serum, and furthermore that both these sera were more potent than culture vaccine immune serum. If only the results with pox and neurovaccine viruses are considered, the similar findings for neurovaccine and culture immune sera speak for their identity, while the differences between these findings and those for pox immune serum would indicate that the latter serum is not identical with the other two. The results with culture vaccine virus, however, suggest the identity of pox and neurovaccine immune sera, and a difference between them and the homologous culture vaccine immune serum.
The second neutralization experiment comprised constant dilution of each immune serum in combination with varying dilutions of the three viruses (Table  IV) . 5 virus dilutions in multiples of ten were employed, beginning with 1:1,000 in the case of pox virus and 1 : 1 in the case of both culture vaccine and neurovaccine virus. The particular dihtion of serum selected was the highest which neu-tralized a particular amount of homologous vires as determined by the results of the preliminary tests previously described on the strength or potency of the sera, that is, pox serum 1:100, neurovaccine serum 1:10, and culture vaccine serum 1:10. The results of this experiment (Table IV) showed that pox immune serum (1: 100) neutralized the 3 highest dilutions of pox virus, 1: 10,000,000 to 1:100,000 and one of the two 1 : 10,000 dilutions. It neutralized neurovaccine, however, in the 1:10,000 and 1: 1,000 dilutions of virus and in one of the 1 : 100 dilutions. All the dilutions of culture vaccine virus were neutralized.
With neurovaccine immune serum (1:10) neutralization of neurovaccine virus occurred in the virus dilutions of 1:10,000 and 1:1,000 (Table IV) . All the dilutions of culture vaccine virus were neutralized. On the other hand, neurovaccine immune serum did not neutralize pox virus in its 1 : 10,000 dilutions nor in one of the 1 : 100,000 dilutions. It should be pointed out, however, that in the previous experiment both the 1:100,000 dilutions of pox virus were neutralized by the 1:10 dilution of neurovaccine immune serum (Table nI) .
The tests with culture vaccine immune serum (1 : 10) showed neutralization of culture vaccine virus in the 3 higher dilutions beginning with 1:100. The serum neutralized the pox virus dilutions of 1:100,000 and above but not those of 1:1,000 and 1:10,000. The reactions with neurovaccine virus were somewhat irregular. Virus dilutions of 1:1,000 and 1 : 10,000 were neutralized; in one each of the 1:10 and 1:100 dilutions neutralization was not obtained, but the results of the duplicate dilutions were equivocal.
From these observations it appears that pox immune serum in dilutions of 1:100 was more efficacious in its neutralizing properties against pox virus than either neurovaccine or culture vaccine immune serum in dilutions of 1:10; furthermore, that its effect against neurovaccine virus was almost as marked as that of neurovaccine immune serum despite the tenfold difference in concentration; and finally, that it was more effective against culture vaccine virus than ten times the concentration of culture vaccine immune serum. In addition, the neutralizing action of pox immune serum (1 : 100) was more powerful against both neurovaccine and culture vaccine viruses than against pox virus. Neurovaccine immune se~m was more efficacious against neurovaccine virus and culture vaccine virus than against pox virus. And culture vaccine immune serum was also more potent against culture vaccine and neurovaccine virus than against pox virus. Pox immune serum in the dilution used, 1:100, neutralized the 1:10,000 dilutions of neurovaccine virus, one and probably both the dilutions of 1 : 1,000 and one of the 1 : 100 dilutions. On the other hand, neuro-vaccine immune serum in dilutions of 1: 10 did not neutralize pox virus in dilutions of 1:1,000 and 1:10,000 nor in 1 of 4 tests with a 1:100,000 dilution (TaMes In and IV). Pox immune serum diluted 1 : 100 neutralized all dilutions of culture vaccine including full strength suspensions. Culture vaccine immune serum diluted 1 : 10 did not neutralize pox virus diluted 1: 1,000 and 1 : 10,000 although it neutralized culture vaccine virus at 1:100 and neurovaccine virus at 1:1,000.
Other comparisons could be made, but enough has been said to indicate the essential features of the findings. Bearing in mind that both neurovaccine immune and culture vaccine immune sera were used in dilutions ten times as concentrated as those of pox immune serum, the results may be summarized as follows: First, the neutralizing properties of pox immune serum against pox virus, neurovaccine virus, and culture vaccine virus were more powerful than those of neurovaccine immune serum or culture vaccine immune serum. And second, with respect to the strength or virulence of the viruses as shown by the cutaneous reactions, the titer of pox virus was higher than that of either neurovaccine virus or culture vaccine virus.
While each immune serum displayed some neutralizing action against the two heterologous viruses, the range of this action as determined by the results of parallel dilutions did not coincide with that shown against the homologous virus. The sera possessed in variable degree common neutralizing properties but complete identity between them could not be demonstrated. It follows, therefore, that the viruses with which the sera were produced possessed some common antigenic relationship but that they were not completely identical one with another.
SUMMARY AND CONCLUSIONS
The results of serum neutralizing tests with the viruses of pox, vaccinia, and virus III disease herewith reported generally agree and supplement the results of reinoculation experiments on immune rabbits reported in the previous paper (1) .
The finding that pox virus is neutralized by pox immune serum indicates that the refractory state of recovered pox rabbits to reinoculation with pox virus and the failure of recovered pox rabbits to con-tract a second pox infection after adequate exposure is to be explained upon the basis of the development of an active immunity.
The failure of virus III immune serum to neutralize pox virus is in agreement with the previous conclusion drawn from the positive results of reinoculation and exposure experiments that there is no specific relationship between pox virus and virus III.
Rabbits which had recovered from a pox infection were completely refractory to inoculation with dermo-(culture) vaccine, while rabbits which had recovered from vaccinia were partially refractory to inoculation with pox virus. Vaccine immune adult rabbits did not show any clinical evidence of pox upon exposure to florid cases, but young recently weaned vaccine immunes developed definite although comparatively mild pox infections. The serum neutralization tests showed that pox immune serum neutralized vaccine virus although the action was not complete as shown by the positive results obtained with high dilutions of serum; vaccine immune serum possessed some but comparatively slight neutralizing properties against pox virus. The results of the crossed inoculation and serum neutralizing experiments with pox and neurovaccine viruses resembled those obtained with pox and dermo-(culture) vaccine but the differences were less pronounced. The differences in virus neutralizing ability on the part of the three immune sera paralleled the differences in virus potency as indicated by the character of the local lesions at the site of injection and by the general character of the clinical manifestations of the infection. The potency or virulence of pox virus was much greater than that of neurovaccine and vastly greater than that of dermo-(culture) vaccine.
The complete identity of pox and vaccine virus could not be established, but a definite relationship between them was demonstrated and this was shown to have an immunological basis. From a practical standpoint vaccination with vaccine virus as a prophylactic measure against rabbit pox was clearly indicated.
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FIGS. 1 through 4. 3, 4, 5, and 9 days respectively after injection. Evolution of the modified cutaneous lesions of rabbit pox virus which developed after intradermal injection of a rabbit with mixtures of full strength culture vaccine immune serum and pox virus diluted 1:1, 1:10, 1:100, and 1:1,000. The complete neutralization of pox virus in the same dilutions by pox immune serum is shown by the negative cutaneous results in the injected areas iust below the lower row of black dots.
